Brief use of the Unmind digital mental health platform

Feasibility and preliminary efficacy of a digital intervention for common mental health problems in working adults: a multi-arm randomised pilot trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN80309011

Enrollment

400

Registered

2021-01-19

Start date

2021-01-25

Completion date

Unknown

Last updated

2022-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Common mental health problems in working adults Mental and Behavioural Disorders

Interventions

Jacobson, Martell, & Dimidjian, 2001), acceptance and commitment therapy (ACT

This study will evaluate three individual self-guided programmes (‘Series’) that feature on the Unmind platform that address the management and/or prevention of common mental health problems. Particip

Beck, 1976), mindfulness meditation (MM

Kabat-Zinn, 1994), behavioural activation (BA

Hayes, Strosahl, & Wilson, 1999), and psychoeducation. This study will focus on evaluating three individual Series that address the topics of stress, anxiety, and resilience, respecti

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Being at least 18 years old 2. Currently residing in the UK 3. Self-identifying as being in full- or part-time employment 4. Having an active account on the Prolific online participant recruitment platform (https://www.prolific.co) 5. Having access to an internet connection via a smartphone or desktop device 6. Being fluent in English

Exclusion criteria

Exclusion criteria: Previous use of the Unmind platform

Design outcomes

Primary

Measure	Time frame
Captured through a combination of objective adherence data (captured via the Unmind platform) and a feedback questionnaire delivered at post-intervention, and will include: 1. Feasibility: Recruitment, intervention uptake, adherence to instructions (the proportion of participants that engage with their assigned Unmind Series, without completing other platform content), and retention (at post-intervention and 1-month follow-up) 2. Acceptability: Intervention adherence (the proportion of participants completing all seven intervention sessions within the study period), participant satisfaction, reasons for discontinuing the intervention, and qualitative feedback 3. Engagement: Average intervention sessions completed, and three questions adapted from Sections A and B of the Mobile App Rating Scale (MARS; Stoyanov et al., 2015) 4. Transferability: One item adapted from Section E of the MARS 5. Relevance: One item assessing subjective relevance of the intervention 6. Adverse effects: One item adapted from recent guidelines on assessing adverse effects (Rozental et al., 2014), and the proportion of participants that deteriorate from pre- to post-intervention across all secondary outcome measures (for each intervention arm and relative to the no-intervention control)	—

Measure

Time frame

Captured through a combination of objective adherence data (captured via the Unmind platform) and a feedback questionnaire delivered at post-intervention, and will include: 1. Feasibility: Recruitment, intervention uptake, adherence to instructions (the proportion of participants that engage with their assigned Unmind Series, without completing other platform content), and retention (at post-intervention and 1-month follow-up) 2. Acceptability: Intervention adherence (the proportion of participants completing all seven intervention sessions within the study period), participant satisfaction, reasons for discontinuing the intervention, and qualitative feedback 3. Engagement: Average intervention sessions completed, and three questions adapted from Sections A and B of the Mobile App Rating Scale (MARS; Stoyanov et al., 2015) 4. Transferability: One item adapted from Section E of the MARS 5. Relevance: One item assessing subjective relevance of the intervention 6. Adverse effects: One item adapted from recent guidelines on assessing adverse effects (Rozental et al., 2014), and the proportion of participants that deteriorate from pre- to post-intervention across all secondary outcome measures (for each intervention arm and relative to the no-intervention control)

—

Secondary

Measure	Time frame
Self-reported measures of common mental health problems (at baseline, post-intervention, and 1-month follow-up) 1. Stress, assessed using the Perceived Stress Scale (PSS; Cohen & Williamson, 1988) adapted for a two-week reporting period (see Baer, Carmody, & Hunsinger, 2012; Cavanagh et al., 2018) 2. Anxiety, assessed using the Generalized Anxiety Disorder-7 scale (GAD-7; Spitzer, Kroenke, Williams, & Lowe, 2006) 3. Depression, assessed using the Patient Health Questionnaire-8 scale (PHQ-8; Kroenke, Spitzer, & Williams, 2001; Kroenke et al., 2009) 4. Resilience, assessed using the Brief Resilience Scale (BRS; Smith et al., 2008) 5. Mental wellbeing, assessed using the Unmind Index	—

Measure

Time frame

Self-reported measures of common mental health problems (at baseline, post-intervention, and 1-month follow-up) 1. Stress, assessed using the Perceived Stress Scale (PSS; Cohen & Williamson, 1988) adapted for a two-week reporting period (see Baer, Carmody, & Hunsinger, 2012; Cavanagh et al., 2018) 2. Anxiety, assessed using the Generalized Anxiety Disorder-7 scale (GAD-7; Spitzer, Kroenke, Williams, & Lowe, 2006) 3. Depression, assessed using the Patient Health Questionnaire-8 scale (PHQ-8; Kroenke, Spitzer, & Williams, 2001; Kroenke et al., 2009) 4. Resilience, assessed using the Brief Resilience Scale (BRS; Smith et al., 2008) 5. Mental wellbeing, assessed using the Unmind Index

—

Countries

England, United Kingdom

Contacts

Public ContactMarcos Economides

marcos.economides@unmind.com-

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 14, 2026